Literature DB >> 19229047

Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.

Jolanta B Perz, Ute Hegenbart, Nicolaus Kroeger, Gerd Otto, Anthony D Ho, Peter Dreger.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19229047      PMCID： PMC2663626          DOI： 10.3324/haematol.2008.002923

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis.

Authors:  S Matthes-Martin; C Peters; A Königsrainer; G Fritsch; T Lion; A Heitger; K Kapelari; M Kronberger; F Offner; F Wrba; R Margreiter; H Gadner
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis.

Authors:  K Kawahara; R Storb; J Sanders; F B Petersen
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

3.  Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

Authors:  Nicolaus Kröger; Anita Badbaran; Ernst Holler; Joachim Hahn; Guido Kobbe; Martin Bornhäuser; Andreas Reiter; Tatjana Zabelina; Axel R Zander; Boris Fehse
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

4.  Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome.

Authors:  J L Perkins; J P Neglia; N K Ramsay; S M Davies
Journal:  Bone Marrow Transplant       Date:  2001-09       Impact factor: 5.483

5.  Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis.

Authors:  M J Dugan; D A Rouch; L P Akard; B G Sperl; J R Black; R E Markham; J Jansen
Journal:  Bone Marrow Transplant       Date:  1993-10       Impact factor: 5.483

6.  Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.

Authors:  Daniella M B Kerbauy; Theodore A Gooley; George E Sale; Mary E D Flowers; Kristine C Doney; George E Georges; Joanne E Greene; Michael Linenberger; Effie Petersdorf; Brenda M Sandmaier; Bart L Scott; Mohamed Sorror; Derek L Stirewalt; F Marc Stewart; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

Review 7.  Should we be performing more combined hematopoietic stem cell plus solid organ transplants?

Authors:  K Y Chiang; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2003-04       Impact factor: 5.483

Review 8.  Microchimerism, dendritic cell progenitors and transplantation tolerance.

Authors:  A W Thomson; L Lu; N Murase; A J Demetris; A S Rao; T E Starzl
Journal:  Stem Cells       Date:  1995-11       Impact factor: 6.277

9.  Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.

Authors:  Nicolaus Kröger; Jürgen Thiele; Axel Zander; Rainer Schwerdtfeger; Guido Kobbe; Martin Bornhäuser; Wolfgang Bethge; Jörg Schubert; Theo de Witte; Hans Michael Kvasnicka
Journal:  Exp Hematol       Date:  2007-11       Impact factor: 3.084

10.  Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Authors:  Francesca Patriarca; Andrea Bacigalupo; Alessandra Sperotto; Miriam Isola; Franca Soldano; Barbara Bruno; Maria Teresa van Lint; Anna Paola Iori; Stella Santarone; Ferdinando Porretto; Pietro Pioltelli; Giuseppe Visani; Pasquale Iacopino; Renato Fanin; Alberto Bosi
Journal:  Haematologica       Date:  2008-08-25       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.